Adult Sinusitis
Published in Otolaryngology–Head and Neck Surgery on April 1.
- Published Guideline
-
- Fluoroquinolone Warning
- On July 8 the Food and Drug Administration notified the manufacturers of fluoroquinolone antimicrobials that black-box warnings must be added to the drugs’ labels to emphasize the increased risk they pose for developing tendinitis and tendon ruptures. Source: Food and Drug Administration, July 8
- Executive Summary
- Plain Language Summary
Adult Sinusitis
- AAO-HNSF Choosing Wisely List of 10 Things Providers and Patients Should Question
- Patient Information Sheet on Diagnosis of Acute Sinusitis
- Patient Information on Treating Acute Bacterial Rhinosinusitis
- Health Information/Patient Education Leaflet
- Decisions aids to help people who are health treatment or screening
Adult Sinusitis
The slide set is available for download here.
Contact the Research & Quality Team at [email protected] for more information.
Adult Sinusitis
Adult Sinusitis
Visit AAO-HNSF’s Otolaryngology Learning Network: www.otologic.org
- AAO-HNSF Clinical Practice Guideline: Adult Sinusitis
- Medical Strategies for Treatment of Refractory Sinusitis
- Treatment of Sinusitis with Integrative East-West Medicine
- AcademyQ CME: Rhinology & Allergy
Adult Sinusitis
Research Needs section from Adult Sinusitis CPG.